Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Arron

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature|December 16, 2000
Bone versus immune systemJ R Arron, Y Choi
The Journal of Biological Chemistry|June 15, 2001
A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activationJ R Arron, M Vologodskaia, B R Wong, et al.
Molecular Cell|January 15, 2000
TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-SrcB R Wong, D Besser, N Kim, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 18, 2013
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challengeH Scheerens, J R Arron, Y Zheng, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature|December 16, 2000
Bone versus immune systemJ R Arron, Y Choi
The Journal of Biological Chemistry|June 15, 2001
A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activationJ R Arron, M Vologodskaia, B R Wong, et al.
Molecular Cell|January 15, 2000
TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-SrcB R Wong, D Besser, N Kim, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 18, 2013
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challengeH Scheerens, J R Arron, Y Zheng, et al.
Pageof 1